doi: 10.1016/S0140-6736(18)32261-X 15 GersteinHCColhounHMDagenaisGRDiazRLakshmananMPaisPet al
J., Gigante, R., Nauck, M
Albiglutide, a long-acting GLP-1 receptor agonist, improves glycemia in type 2 diabetes: time-course analysis [abstract]
Money-Back Guarantee: If your items arrive damaged or become defective within 180 days of normal usage, we will gladly issue a replacement or refund
After discontinuing its internal GLP-1 in May of 2025 for causing liver issues, Pfizer won a bidding war against seven other companies for Metsera, which is developing a variety of incretin assets, paying $10 billion in one of 2025s largest M&A deals
Frequently Asked Questions Explore Personalized Weight Loss Options Start with an online assessment to help a licensed clinician determine whether a prescription weight loss treatment, along with guided nutritional support, may be appropriate for you.